Dr. Matthew D. Cain filed his economic expert testimony supporting the motion for class certification in Bernstein v. Ginkgo Bioworks Holdings, Inc. (Case No. 4:21-cv-08943), with specialized research and economic analysis contributed by Fideres.

Cain’s efficiency evaluation examines whether Ginkgo Bioworks securities traded in an efficient market where material disclosures were rapidly absorbed into share pricing. Fideres applied proven econometric models to examine market structure and price adjustment mechanisms, utilizing comprehensive SPAC litigation and biotechnology sector expertise.

The market efficiency analysis supports fraud-on-the-market theory application, establishing that disclosures about Ginkgo’s revenue sources and related-party relationships were promptly reflected in stock price corrections.